Lornoxicam

Lornoxicam

Clinical data
ATC code	M01AC05 (WHO)
Identifiers
IUPAC name (3E)-6-chloro-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxothieno[2,3-e]thiazin-4-one
PubChem CID	5282204
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C13H10ClN3O4S2
Molar mass	371.8192 g/mol

WikiDoc Resources for Lornoxicam
Articles
Most recent articles on Lornoxicam Most cited articles on Lornoxicam Review articles on Lornoxicam Articles on Lornoxicam in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Lornoxicam Images of Lornoxicam Photos of Lornoxicam Podcasts & MP3s on Lornoxicam Videos on Lornoxicam
Evidence Based Medicine
Cochrane Collaboration on Lornoxicam Bandolier on Lornoxicam TRIP on Lornoxicam
Clinical Trials
Ongoing Trials on Lornoxicam at Clinical Trials.gov Trial results on Lornoxicam Clinical Trials on Lornoxicam at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Lornoxicam NICE Guidance on Lornoxicam NHS PRODIGY Guidance FDA on Lornoxicam CDC on Lornoxicam
Books
Books on Lornoxicam
News
Lornoxicam in the news Be alerted to news on Lornoxicam News trends on Lornoxicam
Commentary
Blogs on Lornoxicam
Definitions
Definitions of Lornoxicam
Patient Resources / Community
Patient resources on Lornoxicam Discussion groups on Lornoxicam Patient Handouts on Lornoxicam Directions to Hospitals Treating Lornoxicam Risk calculators and risk factors for Lornoxicam
Healthcare Provider Resources
Symptoms of Lornoxicam Causes & Risk Factors for Lornoxicam Diagnostic studies for Lornoxicam Treatment of Lornoxicam
Continuing Medical Education (CME)
CME Programs on Lornoxicam
International
Lornoxicam en Espanol Lornoxicam en Francais
Business
Lornoxicam in the Marketplace Patents on Lornoxicam
Experimental / Informatics
List of terms related to Lornoxicam

Overview

Lornoxicam is a non-steroidal anti-inflammatory drug.

mode of action: Lornoxicam readily penetrates into synovial fluid. lornoxicam synovial fluid: plasma AUC ratio is 0.5 after administration of 4mg twice daily.

Template:WH